Multimorbidity in patients with atrial fibrillation

Onderzoeksoutputpeer review

9 Downloads (Pure)

Samenvatting

There is an escalating trend in both the incidence and prevalence of atrial fibrillation (AF). AF is linked to numerous other comorbidities, contributing to the emergence of multimorbidity. The sustained rise in multimorbidity and AF prevalences exerts a significant strain on healthcare systems globally. The understanding of the relation between multimorbidity and AF is essential to determine effective healthcare strategies, improve patient outcomes to adequately address the burden of AF. It not only begins with the accurate identification of comorbidities in the setting of AF. There is also the need to understand the pathophysiology of the different comorbidities and their common interactions, and how multimorbidity influences AF perpetuation. To manage the challenges that rise from the increasing incidence and prevalence of both multimorbidity and AF, such as adverse events and hospitalisations, the treatment of comorbidities in AF has already gained importance and will need to be a primary focus in the forthcoming years. There are numerous challenges to overcome in the treatment of multimorbidity in AF, whereby the identification of comorbidities is essential. Integrated care strategies focused on a comprehensive multimorbidity management with an individual-centred approach need to be determined to improve healthcare strategies and reduce the AF-related risk of frailty, cardiovascular diseases and improve patient outcomes.

Originele taal-2English
Artikelnummere002641
Aantal pagina's7
TijdschriftOpen Heart
Volume11
DOI's
StatusPublished - 19-mrt.-2024

Vingerafdruk

Duik in de onderzoeksthema's van 'Multimorbidity in patients with atrial fibrillation'. Samen vormen ze een unieke vingerafdruk.

Citeer dit